| Financial Year |
March 31 2023 |
| Monetary Funds |
258,527,746.35 |
| Held-for-trading Financial Assets |
121,013,634.02 |
| Notes Receivable |
26,465,131.94 |
| Accounts Receivable |
72,323,669.78 |
| Advances to Suppliers |
6,130,004.17 |
| Other Receivables |
234,036.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
41,243,686.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,060,507.48 |
| Total Current Assets |
544,863,963.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
200,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
205,163.46 |
| Fixed Assetes |
183,020,823.68 |
| Under-construction Projects |
115,149,113.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,967,437.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,737,346.41 |
| Deferred Income Tax Assets |
744,064.74 |
| Other Non-Current Assets |
13,832,249.32 |
| Sub-Total of Non-Current Assets |
372,332,433.23 |
| Total Assets |
917,196,397.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
91,652,300.00 |
| Accounts Payable |
35,951,104.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
680,151.81 |
| Taxes Payable |
509,962.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,066,581.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
162,884.86 |
| Other Current Liabilities |
445,787.45 |
| Sub-Total of Current Liabilities |
139,260,969.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
505,953.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,126,940.73 |
| Total Liabilities |
144,387,910.64 |
| Paid-In Capital(Or Share Stock) |
87,937,500.00 |
| Capital Surplus |
287,352,197.82 |
| Surplus Reserve |
53,561,395.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
341,451,929.66 |
| Minority Stockholder's Interest |
2,640,526.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
770,167,959.95 |
| Owner's Equity（Stockholder's Equity） |
772,808,486.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
917,196,397.01 |
